Telomere, telomerase, tumorigenesis and therapy: an overview

Sen, S. ; Dasgupta, A. ; Roychudhuri, A. ; Mittra, B. ; Majumder, H. K. (1999) Telomere, telomerase, tumorigenesis and therapy: an overview Indian Journal of Experimental Biology, 37 (9). pp. 839-42. ISSN 0019-5189

Full text not available from this repository.

Abstract

The ends of chromosome in higher eukaryote are termed telomere. The DNAs present at that part of chromosome is called telomeric DNA. Telomeric DNA consists of tandemly repeated DNA sequences. The replication of the ends of chromosomes is not controlled by conventional DNA polymerases rather a special kind of enzyme is involved in this process. It is a ribonucleoprotein and known as telomerase. Cells in senescence stage face telomeric crisis that leads to loss of telomeric ends. Surveillance turns to procancer cells with increased telomerase activity which is a later consequence. Based on these facts a key diagnostic approach has been developed for detection of tumour. A novel therapy for tumour repression has been developed using telomerase inhibitors. However, these inhibitors are very much effective for solid tumour therapy and conceptually will not work on hematological malignancies.

Item Type:Article
Source:Copyright of this article belongs to National Institute of Science Communication and Information Resources.
ID Code:72085
Deposited On:28 Nov 2011 05:31
Last Modified:28 Nov 2011 05:31

Repository Staff Only: item control page